# Pique Therapeutics, Inc. — Form D

Pique Therapeutics, Inc. of DURHAM, NC, a company, filed a Form D exempt-offering notice with the SEC on 2018-12-19. The offering totals $1000K, of which $854K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-12-19
- Form: D
- Accession: 0001465515-18-000001
- Industry: Biotechnology
- Exemptions: 04
- Total offering: $1000K
- Amount sold: $854K
- Remaining: $146K
- Minimum investment: $5K
- Investors: 13
- Date of first sale: 2017-07-31
- Security types: equity, debt
- Revenue range: No Revenues
- SEC file number: 021-328478

## Issuer

- Name: Pique Therapeutics, Inc.
- CIK: 0001465515
- Entity type: Corporation
- Jurisdiction: NORTH CAROLINA
- Incorporated: 2005
- Address: 2530 MERIDIAN PARKWAY, DURHAM, NC, 27713
- Phone: 919-806-4395

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| John B Brennan | Director | Greensboro, NC |
| Keith Dionne | Director | Belmont, MA |
| Christopher Meldrum | Director | Durham, NC |
| Ian J Mehr | Executive Officer | Raliegh, NC |
| Christopher Meldrum | Executive Officer | Durham, NC |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2009-06-03](https://search.stillhousedata.com/formd/0001465515-09-000001) | D | $600K | $536K |

## More

- [CIK 1465515 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1465515&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001465515-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.